Zedoary for Wound Healing and Topical Use: A Pediatric Trial and a Thin Preclinical Record

Of the four benefit areas covered in this set, topical and wound-healing use has the thinnest independent evidence — and what exists is unusually confounded by other ingredients, to a degree worth documenting in its own right. This page includes the second of the two genuine human trials found anywhere in this series, and, like the liver trial on the previous page, it has to be read past its headline conclusion to see what it actually showed.

Table of Contents

  1. The Claim
  2. The 2025 Pediatric Dental Plaque Trial, in Full
  3. Reading the Trial: Even Saline “Worked”
  4. The Wound-Healing Polysaccharide Study — and What It Actually Tested
  5. Direct Antimicrobial Screening, With the Arithmetic
  6. A Different Literature Entirely: Nanoparticle Green Synthesis
  7. A Note on Bleeding: Antiplatelet Constituents
  8. Verdict and Evidence Tier
  9. What Is Not Known
  10. Practical Cautions
  11. Key Research Papers
  12. Connections

The Claim

Ayurvedic and Southeast Asian traditions apply zedoary rhizome topically as a paste for bruises, swelling and skin complaints, alongside its internal use, and the main Curcuma zedoaria page documents antimicrobial and antioxidant laboratory screening of the plant already. This page asks a narrower question the main page does not fully answer: is there evidence specific to wound healing and topical antimicrobial use, as distinct from general in-vitro antimicrobial screening in a Petri dish?

The 2025 Pediatric Dental Plaque Trial, in Full

Deshpande and colleagues (2025) ran a randomised controlled trial in 84 hospitalised children aged 3–14, who often cannot perform normal oral hygiene. Four groups of 21 received, twice daily with sterile gauze: extra-virgin olive oil alone; olive oil with 35% Curcuma zedoaria; olive oil with 30% Azadirachta indica (neem); or plain normal saline. Plaque score (Loe and Silness index) and colony-forming-unit counts of Streptococcus mutans, Lactobacillus and Candida albicans were measured at baseline, 24, 48 and 72 hours.

Reading the Trial: Even Saline “Worked”

All four groups — including the plain saline group — showed a statistically significant reduction in plaque score and microbial counts from baseline to 72 hours (p < 0.05). That is the finding to hold onto before reading anything else: mechanical wiping with sterile gauze twice daily reduces plaque and bacterial counts in the mouth regardless of what, if anything, is on the gauze. This is exactly the kind of vehicle-and-mechanical-action confound this site’s doctrine warns about, and it is present here in an unusually clean, visible form because the trial included the inert-vehicle arm needed to show it.

Against that background, the between-group comparison is the part that actually isolates an ingredient effect, and it does not straightforwardly favour zedoary: the trial reports that the neem group showed significantly better antimicrobial activity than the olive-oil, zedoary, and saline groups at 72 hours (p = 0.0001). The paper’s own conclusion sentence states that “EVOO + 35% CZ showed the best treatment outcome” — a claim that sits awkwardly next to the results paragraph’s statement that the neem group’s antimicrobial activity was significantly better than zedoary’s. Both statements appear in the same published abstract; this page reports both rather than silently resolving the discrepancy in zedoary’s favour, and a reader relying on this trial for a zedoary topical-antimicrobial claim should know the paper itself is not fully consistent between its results and its conclusion.

Two further limits: the trial tested a 35% concentration blended into olive oil, not the rhizome or an aqueous preparation, applied to dental plaque, which is a bacterial biofilm on a tooth surface, not a skin wound. Neither the concentration, the vehicle, nor the tissue generalises automatically to a cut, burn, or skin infection.

Back to Table of Contents

The Wound-Healing Polysaccharide Study — and What It Actually Tested

The single study in this literature actually titled around “wound healing” is worth examining closely for what it tested, because the title alone overstates how directly it speaks to a traditional topical application. Xu and colleagues (2018) isolated a polysaccharide (abbreviated ZWP) from zedoary rhizomes and tested it — alone, and combined with platelet-rich plasma exosomes (PRP-Exos) — assembled onto an engineered chitosan/silk hydrogel sponge, applied to diabetic rats with induced wounds. All treatment combinations produced wound contraction, with increased epidermal thickness, increased collagen synthesis, and increased angiogenesis at the wound site; the combination of PRP-exosomes and the zedoary polysaccharide performed better than either component alone.

Read this precisely: the zedoary-derived material here is a single isolated polysaccharide fraction, not the rhizome, not an extract, not an essential oil — and it was delivered on a laboratory-engineered biomaterial scaffold combined with a regenerative-medicine product (platelet exosomes), not as a poultice or paste. This is real, specific evidence that one zedoary-derived molecule contributes to wound closure in an engineered delivery system in diabetic rats. It is not evidence that applying zedoary rhizome, paste or extract to a wound in a person reproduces any part of this effect — the fraction, the vehicle, and the co-administered biological product are all different from anything a reader could replicate outside a laboratory.

Direct Antimicrobial Screening, With the Arithmetic

Beyond the two trials above, a real body of disc-diffusion and broth-dilution antimicrobial screening exists, mostly confirming what the main page already states in general terms — but two papers are specific and detailed enough to add arithmetic, per this site’s standing practice of doing the sum rather than only asserting a caveat.

Back to Table of Contents

A Different Literature Entirely: Nanoparticle Green Synthesis

A specific, easy-to-miss trap is worth naming explicitly, because it inflates the apparent size of the “zedoary antibacterial” literature in a way a simple search-count would not reveal. A cluster of recent papers — zinc oxide nanoparticles synthesised using zedoary and bitter-gourd extract together (2023), and an abscess-focused herbal formulation using zedoary among other biofilm-targeting ingredients (2026) — use zedoary rhizome extract not as the therapeutic agent under test, but as a plant-derived reducing and capping agent in the chemistry of manufacturing metal nanoparticles, a genuinely active and unrelated field of materials science. The antibacterial activity reported in these papers belongs to the resulting zinc oxide or copper oxide nanoparticle, characterised by its own separate mechanism (largely oxidative membrane disruption from the metal oxide surface), not to zedoary itself acting as an antimicrobial agent in any conventional sense. A raw publication count for “Curcuma zedoaria antibacterial” will include these studies; a reader assessing the herb’s own antimicrobial evidence should not.

A Note on Bleeding: Antiplatelet Constituents

A reader drawn to this page by a hemostatic or “stops bleeding” framing for a topical wound remedy should know the opposite finding exists in the literature: Chen and colleagues (2016) isolated new and known sesquiterpenoids from zedoary rhizomes, several of which — including germacrone and curcumin — inhibited both collagen-induced and arachidonic-acid-induced platelet aggregation in vitro, with inhibition ranging from roughly 21% to 95% at 100 µM depending on the specific compound and pathway tested. This connects to, and strengthens with an actual isolated-compound finding, the theoretical anticoagulant caution already carried on the main Curcuma zedoaria page under its “moves blood” classification. It is isolated-compound, in-vitro evidence, not a demonstrated bleeding risk from topical or oral use at traditional doses — but it means zedoary’s own chemistry runs in the anti-clotting direction, not the clot-promoting direction a wound remedy might be assumed to have.

Back to Table of Contents

Verdict and Evidence Tier

Back to Table of Contents

What Is Not Known

  1. No trial exists of zedoary rhizome, paste or simple extract alone, unblended with another ingredient, applied to any actual skin wound in any species.
  2. No human data on zedoary for burns, ulcers, surgical wounds, or any skin infection.
  3. No safety data on skin sensitisation, irritancy or allergic contact dermatitis from topical zedoary in any concentration or preparation.
  4. No dose-response or concentration-finding data for topical use of any kind.
  5. No study has isolated zedoary’s specific contribution in either of the two combination products (the dental-plaque oil blend, the wound-healing hydrogel system) from the other active ingredients present.

Practical Cautions

Zedoary should not be relied on in place of standard wound care for anything beyond the most minor superficial abrasion, and never for a deep, contaminated, diabetic, or non-healing wound, all of which require professional assessment. The main Curcuma zedoaria page’s existing warning against internal use of the steam-distilled essential oil applies with equal force to topical use on broken skin: essential oils are concentrated terpene mixtures that can irritate or sensitise damaged skin, and none of the screening studies above tested the essential oil topically on an actual wound. If a herb with real, better-established topical wound-healing evidence is wanted, see the Connections section below for alternatives with substantially deeper human and animal literatures.

Back to Table of Contents

Key Research Papers

  1. Deshpande A, Baishya S, Dori S, Wadhwa M, Shah K. Clinical and microbiological evaluation of dental plaque on topical application of olive oil, olive oil with 35% Curcuma zedoaria, and olive oil with 30% Azadirachta indica in hospitalized children: a randomized control trial. Journal of the Indian Society of Pedodontics and Preventive Dentistry. 2025;43(2). The trial discussed in full above.
  2. Xu N, Wang L, Guan J, Tang C, He N, Zhang W, Fu S. Wound healing effects of a Curcuma zedoaria polysaccharide with platelet-rich plasma exosomes assembled on chitosan/silk hydrogel sponge in a diabetic rat model. International Journal of Biological Macromolecules. 2018;117. The isolated-fraction, engineered-scaffold study.
  3. Wilson B, Abraham G, Manju VS, et al. Antimicrobial activity of Curcuma zedoaria and Curcuma malabarica tubers. Journal of Ethnopharmacology. 2005;99(1). Shared citation with the main Curcuma zedoaria page.
  4. Budiansyah A, Haroen U, Syafwan S, Kurniawan K. Antioxidant and antibacterial activities of the rhizome extract of Curcuma zedoaria extracted using some organic solvents. Journal of Advanced Veterinary and Animal Research. 2023;10(3). Source of the 2,500 ppm figure.
  5. Ficker CE, Smith ML, Susiarti S, Leaman DJ, Irawati C, Arnason JT. Inhibition of human pathogenic fungi by members of Zingiberaceae used by the Kenyah (Indonesian Borneo). Journal of Ethnopharmacology. 2003;85(2-3).
  6. Riaz T, et al. Assessment of Fumaria indica, Dicliptera bupleuroides and Curcuma zedoaria for their antimicrobial and hemolytic effects. Pakistan Journal of Pharmaceutical Sciences. 2019;32(2). Haemolytic testing is directly relevant to a topical-safety question.
  7. Tadtong S, et al. Phytochemical assessment, evaluation of antioxidant and antibacterial properties, and molecular docking to elucidate the regulation of bacterial biofilm formation in an herbal formulation for the treatment of abscesses. International Journal of Molecular Sciences. 2026;27(4). A multi-ingredient formulation, not zedoary alone.
  8. Ihsan M, et al. Green fabrication, characterization of zinc oxide nanoparticles using plant extract of Momordica charantia and Curcuma zedoaria and their antibacterial and antioxidant activities. Applied Biochemistry and Biotechnology. 2023;195(6). The nanoparticle-synthesis literature discussed above.
  9. Dosoky NS, Setzer WN. Chemical composition and biological activities of essential oils of Curcuma species. Nutrients. 2018;10(9). General essential-oil background across the genus.
  10. Chen JJ, Tsai TH, Liao HR, et al. New sesquiterpenoids and anti-platelet aggregation constituents from the rhizomes of Curcuma zedoaria. Molecules. 2016;21(10). The antiplatelet finding.

Connections

Back to Table of Contents